PRO#1278: A Phase III Study of Fludarabine and Busulfan Versus Fludarabine, Busulfan and Low Dose Total Body Irradiation in Patients Receiving an Allogeneic Hematopoietic Stem Cell Transplant
Phase of Trial: Phase III
Latest Information Update: 11 Aug 2017
At a glance
- Drugs Busulfan (Primary) ; Fludarabine (Primary) ; Antithymocyte globulin
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Myelodysplastic syndromes; Myeloproliferative disorders
- Focus Therapeutic Use
- Acronyms FLUBUTBI
- 08 Aug 2017 The study is now recruiting subjects.
- 08 Aug 2017 Planned End Date changed from 1 Dec 2015 to 1 Aug 2018.
- 08 Aug 2017 Planned primary completion date changed from 1 Dec 2015 to 1 Aug 2018.